Search

Home > GRACEcast Lung Cancer Video > Should Avastin be Added to EGFR TKI Therapy for EGFR Mutation-Positive NSCLC?
Podcast: GRACEcast Lung Cancer Video
Episode:

Should Avastin be Added to EGFR TKI Therapy for EGFR Mutation-Positive NSCLC?
Category: Science & Medicine
Duration: 00:07:48
Publish Date: 2015-10-06 14:00:00
Description:

Dr. Jack West, medical oncologist, reviews evidence in favor of adding Avastin (bevacizumab) to the EGFR inhibitor Tarceva (erlotinib) for patients with lung cancer that harbors an activating EGFR mutation.
Total Play: 0